OMID (Omid Holdings) Research & Development: $ Mil (TTM As of . 20)


What is Omid Holdings Research & Development?

Omid Holdings OMID -0.01% Research & Development is $ Mil as of . 20.

Research & Development is the aggregate amount of research and development expenses during the year. Omid Holdings's Research & Development for the three months ended in . 20 was $0.00 Mil. Omid Holdings does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Omid Holdings  (OTCPK:OMID) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Omid Holdings Research & Development Related Terms

Omid Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Omid Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omid Holdings Research & Development Chart

Omid Holdings Annual Data
Trend
Research & Development

Omid Holdings Quarterly Data
Research & Development

Omid Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $ Mil mean?
Omid Holdings (OMID) has a Research & Development of $ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Omid Holdings and its competitors.
Is Omid Holdings' Research & Development too high?
Omid Holdings' current Research & Development is $ Mil.
How does Omid Holdings' Research & Development compare to competitors?
Omid Holdings' Research & Development of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Omid Holdings and its competitors. Omid Holdings's current Research & Development is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omid Holdings stock overvalued right now?
Omid Holdings (OMID) has a current Research & Development of $ Mil. The current Research & Development is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Omid Holdings (OMID), the current Research & Development is $ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omid Holdings Business Description

Address 1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a publicly-traded health and wellness company that operates a GMP-certified manufacturing facility in Alpha, NJ. The company utilizes its strengths in research, design, development, manufacturing, and marketing to produce a types of products for its internal brands. The company also offers its services as a contract manufacturer for private label brands. With a diverse portfolio of product types, OMID specializes in formulations that contain cannabis extracts as well as other herbal ingredients. The company's objective is to provide quality, integrity, and value to its clients in all of its finished consumer goods.